Article Summary
-
As patient interest in longevity and healthy aging continues to rise, medical practices across the U.S. have a unique opportunity to integrate longevity-focused services into their offerings. This growing field not only addresses patients' desires for a longer, healthier life but also presents a potential new therapeutic area for healthcare providers to grow and scale their practice.
Glossary of Terms
Healthspan: This word was added to the Merriam-Webster dictionary in 2018. It refers to the length of time that a person is healthy, not just alive. We have managed to help people live longer, but those extra living years are not a guarantee that they will be healthy. Hence, the renewed focus on adding healthy days to one’s living.
Longevity: This term refers to life expectancy. According to the Center for Disease Control (CDC), the U.S. life expectancy is 80.2 years for females and 74.8 years for males.
Patients Are Seeking Healthspan Options
Recent surveys reveal that many patients are increasingly motivated to invest in their health and well-being as they age. They seek guidance on nutrition, fitness, sleep, mental health, and preventive measures that can enhance their quality of life.
By positioning your practice as a resource for longevity, you can cater to this demand while fostering deeper patient relationships.
Integrating longevity-related services could involve offering specialized assessments that evaluate a patient’s risk factors for age-related diseases, alongside personalized wellness plans. These plans may include recommendations for:
- Dietary adjustments
- Exercise programs
- Supplementation
- Comprehensive testing
Popular Longevity Products
Empower Pharmacy provides high-quality compounded longevity products that may offer potential health benefits:
Methylene Blue
Integrative practitioners are at the heart of healthcare innovation, always seeking products that can transform conventional paths and significantly reshape wellness routines. Preliminary research suggests methylene blue may aid neuroprotection1, protect cells from oxidative stress2, and potentially help skin health2, positioning it as a promising element in potentially promoting longevity and wellness.
Rapamycin
In recent years, rapamycin has made waves within the field of aging research. Studies have shown that mTOR activity may play a role in the aging process and age-related diseases3.
NAD+ Injection
NAD+ may support skin aging at the cellular level by potentially aiding in cell repair and regeneration. It may help support collagen and elastin production which may help reduce the appearance of fine lines4.
Conclusion: Embracing the Future of Longevity in Healthcare
The growing demand for longevity-focused services presents an exciting opportunity for healthcare provider to expand their offerings and meet the evolving desires of today’s health-conscious patients. Are you ready to take the next step? Now is the time to explore how longevity can redefine patient care and contribute to your practice’s growth.
Prescribe Our Longevity Products Today
1. Rodriguez P, Singh AP, Malloy KE, Zhou W, Barrett DW, Franklin CG, Altmeyer WB, Gutierrez JE, Li J, Heyl BL, Lancaster JL, Gonzalez-Lima F, Duong TQ. Methylene blue modulates functional connectivity in the human brain. Brain Imaging Behav. 2017 Jun;11(3):640-648. doi: 10.1007/s11682-016-9541-6. PMID: 26961091; PMCID: PMC5018244. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018244/
2. Xue H, Thaivalappil A, Cao K. The Potentials of Methylene Blue as an Anti-Aging Drug. Cells. 2021 Dec 1;10(12):3379. doi: 10.3390/cells10123379. PMID: 34943887; PMCID: PMC8699482. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699482/
3. Kaeberlein, T. L., Green, A. S., Haddad, G., Hudson, J., Isman, A., Nyquist, A., Rosen, B., Suh, Y., Zalzala, S., Zhang, X., Blagosklonny, M. V., An, J. Y., & Kaeberlein, M. (2023). Evaluation of off-label rapamycin use to promote healthspan in 333 adults. GeroScience. https://doi.org/10.1007/s11357-023-00818-1
4. Conlon NJ. The Role of NAD+ in Regenerative Medicine. Plast Reconstr Surg. 2022 Oct 1;150(4 Suppl ):41S-48S. doi: 10.1097/PRS.0000000000009673. Epub 2021 Sep 28. PMID: 36170435; PMCID: PMC9512238. https://www.mdpi.com/2076-3921/13/4/425
